Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunity
Andrea Ravelli(The University of Texas MD Anderson Cancer Center), Daniele Generali(University of Trieste), Simone Anfossi(The University of Texas MD Anderson Cancer Center), Maria Rosa Cappelletti(University of Trieste), James M. Reuben(The University of Texas MD Anderson Cancer Center), Francesco Lanza(Istituti Ospitalieri di Cremona), Paolo Pedrazzoli(Policlinico San Matteo Fondazione), Massimo Martino(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Laura Zanotti(Istituti Ospitalieri di Cremona), Manuela Milani(Humanitas University), Daniele Spada(Policlinico San Matteo Fondazione), Angela Gobbi(Istituti Ospitalieri di Cremona), Alberto Bottini(University of Genoa)
Cited by 12
Related Papers
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
|The Journal of Infectious Diseases|1985|408
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
|Bone Marrow Transplantation|2022|378